Haw Par logo

Haw Par(OTC) HAWPF

Market Cap$2.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+427%
5 Year+43%
1 Year+6%
1 Month-13%
$10.80
+0.00%
+0.00Today
Haw Par last closing stock price
MetricPriceDate
Last closeUSD 10.802026-09-10
Haw Par stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.03%USD 12.422026-09-03
1 month-13.03%USD 12.422026-07-22
3 month-7.64%USD 11.692026-03-16
Year to date-9.38%USD 11.922025-12-24
1 year+5.9%USD 10.202025-08-05
3 year+89.43%USD 5.702023-08-14
5 year+43.44%USD 7.532021-07-23
Since inception+426.95%USD 2.052003-07-14

Haw Par Financials at a Glance

Market Cap

$2.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SGD 472.31M

Net Income (TTM)

SGD 479.32M

EPS (TTM)

$0.81

P/E Ratio

13.40

Dividend

$0.32

Beta (Volatility)

-0.01 (Low)

Price

$10.80

Volume

101

Open

$10.80

Previous Close

$10.80

Daily Range

$10.80 - $10.80

52-Week Range

$10.66 - $14.17

Estimated Earnings Date

Aug 14, 2026

HAWPF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haw Par

Haw Par Corporation Limited, established in 1969 and headquartered in Singapore, operates in the healthcare sector, focusing on the manufacturing and distribution of healthcare products. The company is well-known for its flagship brands, including Tiger Balm, and has diversified interests in investments and leisure activities.

Products and Services
  • Topical analgesic solutions, primarily Tiger Balm and Kwan Loong
  • Investment in publicly traded securities and leasing of commercial properties
  • Leisure and entertainment experiences, including oceanariums
Growth Outlook
  • Revenue increased to SGD 115.7 million in Q2 2026, up from SGD 103.5 million in Q4 2025
  • Net income reached SGD 107.7 million in Q2 2026, reflecting strong operational efficiency
  • Current ratio of 7.17 indicates robust liquidity and financial health
Financial Highlights
  • Trailing twelve-month revenue of SGD 474.5 million, showcasing consistent growth
  • Dividend yield of 2.99%, providing attractive returns to shareholders
  • Net profit margin of 1.04% indicates effective cost management
Haw Par Corporation Limited has established a strong presence in the healthcare market, particularly with its well-recognized products. The company's diversified operations, including investments and leisure activities, contribute to its overall stability and growth potential. Recent financial performance highlights a significant increase in revenue and net income, demonstrating effective management and operational efficiency. The strong liquidity position, as indicated by the current ratio, further supports the company's ability to navigate market challenges. With a solid dividend yield, Haw Par Corporation Limited presents an interesting opportunity for investors seeking exposure to the healthcare sector.
AI Generated • Sep 15, 2026

Industry

Pharmaceuticals

CEO

Ee Lim Wee

Headquarters

Singapore, NW 149598, SG

HAWPF Financials

Key Financial Metrics (TTM)

Gross Margin

55.54%

Operating Margin

30.50%

Net Income Margin

104.39%

Return on Equity

5.07%

Return on Capital

1.55%

Return on Assets

4.70%

Earnings Yield

7.46%

Dividend Yield

2.92%

Payout Ratio

38.64%

Stock Overview

Market Cap

$2.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

221.37M

Volume

101

Avg. Volume

5.5

Financials (TTM)

Gross Profit

SGD 262.85M

Operating Income

SGD 132.67M

EBITDA

SGD 145.08M

Operating Cash Flow

SGD 291.08M

Capital Expenditure

-SGD 4.76M

Free Cash Flow

SGD 286.32M

Cash & ST Invst.

SGD 879.79M

Total Debt

SGD 52.51M

Haw Par Performance Analysis

Haw Par annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SGD 132,047,45025.7%
20232023-12-31SGD 172,774,19830.8%
20242024-12-31SGD 183,195,2726.0%
20252025-12-31SGD 176,004,916-3.9%
Haw Par sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-317.3%
Q22025-06-30-0.3%
Q42025-12-31-18.0%
Q22026-06-3011.8%
Haw Par annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SGD 0.4931.3%
20232023-12-31SGD 0.7349.9%
20242024-12-31SGD 0.775.9%
20252025-12-31SGD 0.9218.9%
Haw Par sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-12.7%
Q22025-06-3035.4%
Q42025-12-31-15.4%
Q22026-06-30-10.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SGD 115.72M

-2.0%

Gross Profit

SGD 64.50M

+0.1%

Gross Margin

55.74%

N/A

Market Cap

$2.39BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.02M

N/A

Employees

595

N/A

Net Income

SGD 107.68M

-11.7%

EBITDA

SGD 36.24M

+5.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SGD 879.79M

+82.2%

Total Debt

SGD 52.51M

+44.7%

Accounts Receivable

SGD 46.03M

-13.5%

Inventory

SGD 24.29M

+13.3%

Long Term Debt

SGD 0.00

N/A

Short Term Debt

SGD 52.51M

+44.7%

Return on Assets

4.70%

N/A

Return on Invested Capital

1.41%

N/A

Free Cash Flow

SGD 99.73M

+567.8%

Operating Cash Flow

SGD 100.97M

+494.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HTSUFHisamitsu Pharmaceutical Co., Inc.
$29.00+0.00%
CURLFCuraleaf Holdings, Inc.
$11.04-2.30%
APNHYAspen Pharmacare Holdings Limited
$9.58-4.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.54+3.55%
INTCIntel
$123.00-3.45%
NVDANvidia
$225.07+0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.94-3.02%

Questions About HAWPF

What is the current price of Haw Par?

Haw Par is trading at $10.80 per share.

What is the 52-week range for Haw Par?

Over the past 52 weeks, Haw Par has traded between $10.66 and $14.17.

How much debt does Haw Par have?

As of the most recent reporting period, Haw Par reported total debt of SGD 34.75M.

How much cash does Haw Par have on hand?

Haw Par reported SGD 615.42M in cash and cash equivalents in its most recent financial results.

What is Haw Par’s dividend yield?

Haw Par currently has a dividend yield of 2.92%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.